IP Verse

Wilk patent opposition analysis

The comprehensive analysis of Wilk opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Wilk

Stay updated with the latest patent oppositions filed by Wilk

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4108671
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 20, 2025BIONTECH
EP3981437
Nucleic Acid VaccinesMODERNAJul 9, 2025BIONTECH
EP4023249
Nucleic Acid VaccinesMODERNAJul 9, 2025BIONTECH
EP3324979
Infectious Disease VaccinesMODERNAJul 10, 2023BIONTECH
EP2791160
Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNADec 2, 2022BIONTECH
EP3590949
Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNASep 23, 2022BIONTECH
EP3134131
Nucleic Acid VaccinesMODERNASep 22, 2022BIONTECH
EP3682905
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 29, 2022BIONTECH
EP2976418
A Method For Producing A Product (E.G. Polypeptide) In A Continuous Cell Culture Fermentation Process.CMC BIOLOGICSJun 30, 2021WILK
EP3492109
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNADec 4, 2020BIONTECH

Top clients of Wilk

Top companies who are the clients of Wilk

CompanyTotal
BIONTECH10
BIONTECH CELL & GENE THERAPIES1
VICTREX MANUFACTURING1
WILK1